Dr Reddys plans to launch value-added drugs in US as part of diversification, market entry strategy Medical Dialogues Bureau8 July 2019 1:32 PM ISTAs part of the diversification and new market entry strategy, DRL (Dr Reddys) plans to re-focus some of its Research and Development resources to...
Dr Reddys gets two USFDA observations for Vizag plants Farhat Nasim24 Jun 2019 11:09 AM ISTHyderabad: City-based Dr Reddy's Laboratories (Dr Reddys/ DRL) has reportedly fallen under the US health regulator's scanner. The company has been...
Dr Reddys yields positive results from phase 2b study of new psoriasis drug Farhat Nasim10 Jun 2019 2:02 PM ISTThe detailed safety and efficacy data from the study would be presented in future dermatology conferences, reads Dr Reddy's (Dr Reddys) recent...
Dr Reddy's Laboratories in process to seek permission for launch of 70 products in China Farhat Nasim3 Jun 2019 11:00 AM ISTDr Reddy's Chief Operations Officer, Erez Israeli in a recent earnings call said the drug-maker is in the process of seeking necessary approvals from...
Dr Reddys Vizag unit gets 6 observations by German regulator Ruby Khatun Khatun9 Sept 2017 9:32 AM ISTNew Delhi: Dr Reddy's Laboratories (DRL) said the German drug regulator has concluded the audit of its Visakhapatnam formulations facility with six...
Dr Reddy Labs inks pact with Amgen to market three drugs in India savita thakur thakur18 Sept 2016 9:34 AM ISTHyderabad : Dr Reddy's Laboratories (DRL) has expanded its strategic collaboration with US based independent biotechnology firm Amgen to market and...
